Company Info
Phone(585) 271-2700
Year Established
1997
Ticker
VCNX
Exchange
Nasdaq
Contacts
John E. Leonard, Ph.D.Senior VP, Development & Officer
Maurice Zauderer, Ph.D.
Founder, President & CEO
Jill Sanchez, CPA
CFO
Ernest Smith, Ph.D.
Senior VP, R&D & CSO
Elizabeth E. Evans, Ph.D.
COO & Sr. VP, Discovery & Translational Medicine
John E. Leonard, Ph.D.
Senior VP, Development
Company Description
Vaccinex is pioneering a differentiated approach to treating neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D), a key driver of neuroinflammation.
